SARMs in Las Vegas: Legal Status, Retail Reality, and What the Evidence Shows
No SARM is approved by the FDA for human use anywhere in the United States, including Nevada, and products sold under that label in or shipped to Las Vegas are unapproved drugs with a documented history of contamination and mislabeling.
Key takeaways
What people searching "SARMs Las Vegas" are usually looking for
Searches that combine a drug class with a city name typically reflect one of three intentions: finding a local supplement or nutrition store that stocks SARM-labeled products, checking whether it is legal to buy or possess them in Nevada, or trying to understand why SARMs keep coming up in Las Vegas sports news, since the city is home to major combat sports promotions and the Nevada Athletic Commission (NSAC), which conducts drug testing for boxing and mixed martial arts events held there. This page addresses all three angles using primary sources: FDA statements and warning letters, Department of Justice records, NSAC-related sports reporting, and peer-reviewed toxicology and case-report literature.
The short answer is that federal law applies uniformly across all fifty states. Nevada has no exemption for SARMs. Products marketed as SARMs are not lawfully sold as dietary supplements or as approved drugs anywhere in the country, regardless of local store signage or a website's geo-targeting.
Federal legal status: no SARM is FDA-approved, in Nevada or elsewhere
The FDA has stated plainly that these bodybuilding products are chemical substances that mimic the effects of testosterone and anabolic steroids, and that <cite index="2-1">the substances are not FDA approved and cannot be marketed legally in the U.S. as a dietary supplement or drug.</cite> The agency has said <cite index="1-8">it has issued warning letters to companies selling these products and pursued criminal actions for distributors.</cite>
A representative round of enforcement targeted three companies at once. In an FDA warning letter to one of them, the agency wrote that <cite index="20-3,20-4">the firm's distribution of the products "Ostarine MK2866" and "LGD MAX" violates the Federal Food, Drug, and Cosmetic Act because the FDA has significant safety concerns about products marketed as dietary supplements that contain selective androgen receptor modulators (SARMs).</cite> Trade press coverage of the same action confirmed that <cite index="15-2">the FDA issued warning letters to several companies, including Infantry Labs, LLC, IronMagLabs and Panther Sports Nutrition, for distributing products that contain selective androgen receptor modulators, or SARMs,</cite> and that officials stated <cite index="15-5">although the products identified in the warning letters are marketed and labeled as dietary supplements, the products are unapproved drugs that have not been reviewed by the FDA for safety and effectiveness.</cite>
Criminal prosecution has also occurred. The owner of a South Carolina supplement company was sentenced after admitting he distributed SARMs under the guise of dietary supplements. According to the Department of Justice, <cite index="54-2">John F. Cochcroft pleaded guilty to one count of introduction of a new drug into interstate commerce with the intent to defraud and mislead and one count of manufacturing and possessing with the intent to distribute and distributing anabolic steroids,</cite> and <cite index="54-1">he was sentenced to one day and one year of imprisonment for manufacturing and shipping unapproved drugs and anabolic steroids.</cite> As part of the case, <cite index="54-3">Cochcroft agreed to pay a forfeiture money judgment of $200,000 related to proceeds from his sales of illicit products,</cite> and prosecutors noted that <cite index="54-6">he admitted that some of these products contained osterine [ostarine], a type of synthetic steroid known as a Selective Androgen Receptor Modulator (SARM).</cite> Nevada retailers and distributors are subject to the same federal Food, Drug and Cosmetic Act provisions applied in that case; there is no state-level exception that makes the sale or possession of SARM-labeled products lawful in Las Vegas.
Las Vegas has also been the site of FDA enforcement involving a related category of unapproved bodybuilding products. The agency warned that <cite index="10-1">consumers should avoid dietary supplements sold by a Las Vegas company because they may contain anabolic steroids that can cause liver damage,</cite> after <cite index="10-2">the agency began investigating Tri-Methyl Xtreme supplements following three reported injuries from users in California, New Jersey and Utah.</cite> That case involved undeclared anabolic steroids rather than SARMs specifically, but it illustrates that the city has been directly involved in FDA cases concerning unapproved, mislabeled bodybuilding products of exactly this type.
"Research chemical" storefronts and online sellers: what is actually in the bottle
A large share of the market, including product lines that ship to or are sold near Las Vegas, is labeled "not for human consumption, research use only" or as a dietary supplement, while marketing copy and dosing charts are aimed squarely at consumers. Independent laboratory testing has repeatedly found that these labels do not reliably describe contents.
The most cited analysis, published in JAMA in 2017, purchased 44 products marketed online as SARMs and tested them using anti-doping laboratory protocols. The researchers reported that <cite index="28-21">among 44 products marketed and sold as selective androgen receptor modulators, only 23 (52%) contained one or more selective androgen receptor modulators (Ostarine, LGD-4033, or Andarine).</cite> An additional <cite index="28-22">17 products (39%) contained another unapproved drug, including the growth hormone secretagogue ibutamoren, the peroxisome proliferator-activated receptor-δ agonist GW501516, and the Rev-ErbA agonist SR9009.</cite> Overall, <cite index="28-23">no active compound was detected in 4 of the 44 products (9%) and substances not listed on the label were contained in 11 (25%).</cite> Even when a labeled SARM was present, the stated dose was frequently wrong: <cite index="28-24,28-25">in only 18 of the 44 products (41%) did the amount of active compound match what was listed on the label, and the amount differed substantially from the label in 26 of 44 products (59%).</cite>
A more recent investigation of the European market found comparable problems. Testing of products purchased online and marketed as SARMs found that <cite index="30-2,30-3">the copresence of more than one active substance was observed in more than 60% of samples, and quantitative analysis showed nonuniform content ranging from 30% to 90% of the label claim.</cite> The same study found that <cite index="30-1">other undeclared pharmaceutical substances, including tamoxifen, clomifene, testosterone, epimethandienone, and tadalafil, were measured in 30% of samples,</cite> and concluded that <cite index="30-7">SARMs sold online as food-supplement-like products represent a health hazard due to the presence of unapproved and undeclared active substances.</cite> A shop in Las Vegas or a website shipping to Nevada that offers a SARM-labeled capsule or liquid is operating in this same unregulated supply chain; there is no independent verification mechanism that assures buyers of purity, correct dose, or absence of contaminants.
Las Vegas combat sports: why SARMs show up in Nevada Athletic Commission cases
Las Vegas is a hub for professional boxing and mixed martial arts, and the Nevada Athletic Commission conducts anti-doping testing for most major cards held in the state, including many UFC events. SARMs are formally banned from competition: according to USADA, which administers the UFC's anti-doping program, <cite index="5-8">SARMs are listed in the category of "Other Anabolic Agents" under section S1.2 of the WADA Prohibited List,</cite> and <cite index="5-7">all SARMs are prohibited at all times, both in and out of competition, for all athletes.</cite>
NSAC enforcement actions illustrate this in practice. In one widely reported case, a UFC fighter's post-fight sample came back positive: <cite index="35-7">Barriault tested positive for the banned substance ostarine, a performance-enhancer in the family of selective androgen receptor modulators.</cite> Under commission rules at the time, <cite index="35-14">the commission could suspend a fighter for ostarine use anywhere between nine months and two years,</cite> and the fighter's own account echoed the contamination problems documented in the laboratory studies above: he stated in a written response that <cite index="35-11,35-12">he did not intentionally ingest ostarine, that his positive was for a trace amount, and that the substance is frequently found unlisted in dietary supplements, and he believed a contaminated supplement caused the result.</cite> That case was ultimately resolved by USADA with <cite index="34-1">a six-month period of ineligibility, consistent with low-level ostarine cases with evidence of contamination, after finding no evidence of intentional use.</cite>
Testing extends beyond title-level cards to developmental events. An up-and-coming prospect on Dana White's Contender Series was also suspended by the commission for an ostarine-related finding: <cite index="36-2,36-4">the Nevada State Athletic Commission temporarily suspended Kyler Phillips for a positive out-of-competition drug test for the banned substance ostarine, a decision made during the NSAC's monthly meeting in Las Vegas.</cite> UFC prospect Sean O'Malley was separately suspended twice for ostarine-related positives under the NSAC's jurisdiction, with the commission noting in one instance that <cite index="38-9">ostarine is a selective androgen receptor modulator (SARM) that has commonly come up in contaminated supplements since the U.S. Anti-Doping Agency began running the UFC's anti-doping program in 2015.</cite>
For anyone training for or competing in a sanctioned Nevada bout, the practical implication is that any SARM-labeled product, whether purchased from a Las Vegas retail outlet or online, carries a meaningful risk of an adverse analytical finding even without intent to use a banned substance, given how frequently these compounds turn up as undisclosed contaminants in other products.
Documented health risks in the medical literature
Health regulators have been explicit about the range of harms reported. The FDA states that <cite index="2-5">SARMs have been associated with increased risk of heart attack or stroke, psychosis, sleep disturbances, sexual dysfunction, liver injury/failure, infertility, pregnancy miscarriage and testicular shrinkage.</cite>
Liver injury is the most extensively documented harm in the published case-report literature. The National Institutes of Health's LiverTox database notes that <cite index="43-1">several SARMs are available in dietary supplements, either advertised as such or present as contaminants, for recreational use in bodybuilding, and have been implicated in multiple cases of severe cholestatic jaundice that resembles anabolic steroid jaundice.</cite> LiverTox describes these compounds mechanistically as <cite index="43-2,43-3">a group of compounds that bind selectively to androgen receptors with anabolic but little or no androgenic activity, with the tissue selectivity arising not from variation in the receptor itself but from tissue-specific regulatory proteins that preferentially activate androgen receptor function in bone and muscle.</cite>
Individual case reports corroborate a consistent clinical pattern across different SARMs. One case report described a patient who developed drug-induced liver injury with a cholestatic pattern on biopsy, later confirmed as <cite index="42-1">a diagnosis of drug-induced liver injury (DILI) secondary to the use of SARM supplements,</cite> with the patient still experiencing <cite index="42-4">jaundice, easy fatigability, and pruritus at one week of follow-up</cite> despite stopping the product. A separate case involving RAD-140 documented that <cite index="45-1,45-2,45-3">the patient experienced jaundice and elevated liver enzymes after three months of RAD-140 use, a liver ultrasound revealed hepatic steatosis and a hyperechoic lesion, and symptoms resolved after discontinuing RAD-140.</cite> The authors of that report concluded that <cite index="45-4,45-5">similar cases of liver injury associated with RAD-140 have been reported, highlighting the potential hepatotoxicity of this SARM, and that while discontinuation appears to reverse the injury, the long-term effects and risks of SARM use remain unclear.</cite>
A 2025 report described the first documented pediatric case: <cite index="46-6,46-7">the first known adolescent case of SARMs-associated liver injury with a primarily hepatocellular pattern of injury, whereas previous reports in adults had shown a primarily cholestatic pattern.</cite> A separate 2025 review summarized the broader picture, noting that <cite index="44-1">a growing body of evidence suggests that SARMs can lead to a range of hepatic toxicities, from mild liver enzyme elevations to more severe manifestations such as cholestasis and acute liver failure.</cite>
The overall strength of evidence for liver toxicity is best described as a consistent and growing signal built on individual case reports and small case series rather than large randomized trials. That evidentiary pattern is expected: these substances are not approved for human use, so they cannot ethically be studied in controlled long-term trials at the doses typically taken recreationally. The evidence for cardiovascular, psychiatric, and reproductive harms cited by the FDA rests on adverse-event reports and mechanistic concerns about androgen suppression rather than controlled clinical studies, and should be read as a documented safety signal rather than a fully quantified risk estimate.
Bottom line for the Las Vegas search
Whether the underlying question is where to buy a SARM-labeled product in Las Vegas, whether doing so is legal, or why these compounds appear so often in Nevada combat sports headlines, the evidentiary picture is the same. No SARM has FDA approval for any use, federal enforcement has repeatedly targeted companies and individuals selling them, independent testing shows the retail and online supply is inconsistently labeled and sometimes contaminated with other unapproved drugs, and the published case-report literature documents real, sometimes severe liver injury associated with their use. Local geography does not change any of this.
Frequently asked
This page is for education and does not provide medical or legal advice. No SARM is approved for human use.